During the past decade, Nevada Kidney Disease and Hypertension Centers conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Nevada Kidney Disease and Hypertension Centers" are "ADPKD" (1 trials), "Autosomal Dominant Polycystic Kidney Disease" (1 trials), "Glomerulosclerosis, Focal Segmental" (1 trials), "Polycystic Kidney, Autosomal Dominant" (1 trials) and "Proteinuric Kidney Disease" (1 trials). Many other conditions were trialed in "Nevada Kidney Disease and Hypertension Centers" in a lesser frequency.

Most popular intervention types in "Nevada Kidney Disease and Hypertension Centers" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "VX-147" (2 trials) and "RGLS8429" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nevada Kidney Disease and Hypertension Centers" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Nevada Kidney Disease and Hypertension Centers". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Nevada Kidney Disease and Hypertension Centers, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nevada Kidney Disease and Hypertension Centers, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".